These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21470000)

  • 1. A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.
    Schaepelynck P; Renard E; Jeandidier N; Hanaire H; Fermon C; Rudoni S; Catargi B; Riveline JP; Guerci B; Millot L; Martin JF; Sola A;
    Diabetes Technol Ther; 2011 Jun; 13(6):657-60. PubMed ID: 21470000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
    Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
    Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
    Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.
    Nixon R; Folwell R; Pickup JC
    Diabet Med; 2014 Oct; 31(10):1174-7. PubMed ID: 24804864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.
    Picard S; Hanaire H; Baillot-Rudoni S; Gilbert-Bonnemaison E; Not D; Reznik Y; Guerci B
    Diabetes Technol Ther; 2016 Mar; 18(3):127-35. PubMed ID: 26950530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
    Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
    Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Kleefstra N; Bilo HJ
    BMC Endocr Disord; 2014 Apr; 14():30. PubMed ID: 24708696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P; Juuti M; Walle T; Laatikainen T
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
    Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
    Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia.
    Restrepo-Moreno M; Ramírez-Rincón A; Hincapié-García J; Palacio A; Monsalve-Arango C; Aristizabal-Henao N; Restrepo-Zapata C; Botero-Arango JF
    J Matern Fetal Neonatal Med; 2018 Mar; 31(6):696-700. PubMed ID: 28264604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.